Evolus Inc. (EOLS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Evolus Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.63
+3.60% today
Market cap
$487M
Overall quality
49/100
Kronos AI 30-day
−0.3%
4 of 8 simulated paths end higher
Evolus Inc. (EOLS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $487M. It trades at $7.63, up 3.60% today. Its overall quality score is 49 out of 100, ranked against the whole US market. 5 analysts' average target of $14.33 implies +87.8% from today's price. Kronos AI's 30-day forecast is −0.3% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $14.33 |
| Low – high | $13.00 – $17.00 |
| Analysts | 5 |
| Upside to average | +87.8% |
Kronos AI 30-day forecast
| Expected close | $7.34 (−0.3%) |
| Likely range | −14.6% … +8.6% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 35 |
| Solvency | 36 |
| Growth | 75 |
| Overall | 49 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.